medigraphic.com
Colegio de Medicina Interna de México.

2013, Number 4

<< Back Next >>

Med Int Mex 2013; 29 (4)

Eclampsia and Complete HELLP Syndrome: the Extreme of Obstetric Complication

Vázquez-Flores AD, Domínguez-Borgua A, Queza-Burgos C, Cortés-Contreras DK, Martin JF

Language: Spanish
References: 21
Page: 424-430
PDF size: 178.23 Kb.


ABSTRACT

Preeclampsia is a multisystemic disorder with clinical criteria which have not changed in the last decade: gestational age of 20 weeks, blood pressure above 140/90 mmHg, test strip with 1 + or spot urine sample with 30 mg of proteins in two samples of 4 to 6 h. Globally it represents 10% to 15% of maternal deaths, some epidemiological sources reported immunological, thrombotic, bad adaptation on placenta, oxidative stress and genetic factors as etiological hypothesis. This disease can threat life and increase maternal and child morbidity and mortality with risk of 20% to seven years of hypertension and microalbuminuria.


REFERENCES

  1. Uzan J, Carbonnel M, Piconne O. Pre-eclampsia: pathophysiology, diagnosis, and management. Vasc Health Risk Manag 2011;7:467-474.

  2. Leeman L, Fontaine P. Hypertensive disorders of Pregnancy. Ame Fam Phys 2008;78.

  3. Williams PJ, Morgan L. The role of genetics in preeclampsia and potential pharmacogenomic interventions. Pharmacogenomics Pers Med 2012;5:37-51.

  4. Williams PJ, Broughton F. The genetics of pre-eclampsia and other hypertensive disorders of pregnancy. Best Prac Res Clinl Obstet Gynaecol 2011;25:405-417.

  5. Steegers EA, Von Dadelszen P, Duvekot JJ, Pijnenborg R. Pre-eclampsia. Lancet 2010; 376:631-644.

  6. Christopher WG, Redman I, Sargent L. Immunology of Pre-eclampsia. Am J Reprod Immunol 2010;63:534-543.

  7. Magalhaes A, Freire T, Tolentino M, Casulari L. Antioxidants for preventing pre-eclampsia: A Systematic Review. The Scientific World Journal.

  8. Rammer W, Ahmed A. Is inflammation the cause of preeclampsia? Biochem Soc Trans 2011;39:1619-1627.

  9. Silasi M, Cohen B, Karumanchi SA, Rana S. Abnormal placentation, angiogenic factors, and the pathogenesis of pre-eclampsia. Obstet Gynecol Clin N Am 2010;37:239- 253.

  10. Foley MR, Strong, TH, Garite T. Obstetric Intensive Care Manual. 3rd ed. McGraw-Hill, 2011.

  11. NICE clinical guidelines 107: Hypertension in pregnancy: the management of hypertensive disorders during pregnancy. National Institute for Health and Clinical Excellence, 2010.

  12. Leis MT, Rodríguez MR, García MA, Baptista HA. Guías de práctica clínica. Diagnóstico y tratamiento de la preclampsia- eclampsia. Ginecol Obstet Mex 2010;78:S461- S525.

  13. Sibai BM, Stella CL. Diagnosis and management of atypical preeclampsia-eclampsia, Am J Obstet Gynecol 2009;200:481.e1-481.e7.

  14. Bellomo G, Venanzi S, Saronio P, Verducci C et al. Prognostic significance of serum uric acid in women with gestational hypertension. Hypertension 2011;58:704- 708.

  15. Martin JN, Rose CH, Briery CM, Understanding and managing HELLP syndrome: The integral role of aggressive glucocorticoids for mother and child. Am J Obstet Gynecol 2006;195:914-934.

  16. Noris M, Perico N, Remuzzi G. Mechanisms of disease: pre-eclampsia. Nat Clin Prac Nephrol 2005;1:98-114.

  17. Rath W, Fischer T. The diagnosis and treatment of hypertensive disorders of pregnancy. Dtsch Arztebl Int 2009;106:733-738.

  18. Eiland E, Nzerue C, Faulkner M. Pre-eclampsia. J Pregnancy 2012.

  19. Euser AG, Cipolla MJ. Magnesium sulfate for the treatment of eclampsia: A brief review. Stroke 2009;40:1169-1175.

  20. Stead LG. Seizures in pregnancy/eclampsia. Emerg Med Clin N Am 2011;29:109-116.

  21. Romero JF, Morales E, García M, Peralta ML. Guía de práctica clínica. Preeclampsia-eclampsia. Rev Med Inst Mex Seguro Soc 2012;50:569-579.




2020     |     www.medigraphic.com